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a b s t r a c t
Background: Obesity is associated with depression. This study aimed to evaluate whether clinical
depression is reduced after bariatric surgery (BS).
Methods: Obese adults who received BS procedures from 2002 to 2014 were sampled from the UK
Clinical Practice Research Datalink. An interrupted time series design, with matched controls, was
conducted from three years before, to a maximum of seven years after surgery. Controls were matched
for body mass index (BMI), age, gender and year of procedure. Clinical depression was deﬁned as a
medical diagnosis recorded in year, or an antidepressant prescribed in year to a participant ever
diagnosed with depression. Adjusted odds ratios (AOR) were estimated.
Results: There were 3045 participants (mean age 45.9; mean BMI 44.0 kg/m2) who received BS, including
laparoscopic gastric banding in 1297 (43%), gastric bypass in 1265 (42%), sleeve gastrectomy in 477 (16%)
and six undeﬁned. Before surgery, 36% of BS participants, and 21% of controls, had clinical depression;
between-group AOR, 2.02, 95%CI 1.75–2.33, Po0.001. In the second post-operative year 32% had
depression; AOR, compared to time without surgery, 0.83 (0.76–0.90, Po0.001). By the seventh year,
the prevalence of depression increased to 37%; AOR 0.99 (0.76–1.29, P¼0.959).
Limitations: Despite matching there were differences in depression between BS and control patients,
representing the highly selective nature of BS.
Conclusions: Depression is frequent among individuals selected to undergo bariatric surgery. Bariatric
surgery may be associated with a modest reduction in clinical depression over the initial post-operative
years but this is not maintained.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
The relationship between obesity and depression is complex.
Obese people are at higher risk of depression but depression is also
a predictor of weight gain and future obesity (Luppino et al., 2010).
People who are obese experience the onset of morbidity at younger
ages than those with lower body weight (Booth et al., 2014) and the
multiple morbidities associated with obesity may contribute to a
higher prevalence of depression (Bhattarai et al., 2013). Bariatric
surgery is an increasingly accepted treatment option in obese
patients being recommended for those with morbid obesity (body
mass index, BMI Z40 kg/m2), as well as those with severe obesity
(BMI Z35 kg/m2) if there are weight-related co-morbidities not
responding to medical management (National Institute for Health
and Clinical Excellence, 2006). Access to bariatric surgery is pre-
sently limited, patients undergoing bariatric surgery for obesity
represent a highly selected group, often with a high prevalence of
clinical depression (Kalarchian et al., 2007, Sarwer et al., 2004).
There is now increasing evidence from randomised controlled
trials that bariatric surgery is associated with substantial weight loss
and remission of diabetes (Gloy et al., 2013) with evidence of wider
beneﬁts suggested by non-randomised studies with long-term follow-
up (Arterburn and Courcoulas, 2014). However, evidence for an effect
of BS on depression is limited. Several longitudinal studies have
explored the relationship between bariatric surgery and depression,
identifying signiﬁcant reductions in depression (Burgmer et al., 2007)
Contents lists available at ScienceDirect
journal homepage: www.elsevier.com/locate/jad
Journal of Affective Disorders
http://dx.doi.org/10.1016/j.jad.2014.12.050
0165-0327/& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Abbreviations: AOR, Adjusted odds ratio; BS, Bariatric surgery; BMI, Body mass
index; CPRD, Clinical Practice Research Database; CHD, Coronary heart disease;
LAGB, Laparoscopic adjustable gastric banding; WHO, World Health Organisation
n Corresponding author at: King's College London, Department of Primary Care
and Public Health, 6th Floor, Capital House, 42 Weston Street, London SE1 3QD,
United Kingdom. Tel.: þ44 207 8486631; fax: þ44 207 8486620.
E-mail address: martin.gulliford@kcl.ac.uk (M.C. Gulliford).
Journal of Affective Disorders 174 (2015) 644–649
and depressive symptoms (Dixon et al., 2003, Mitchell et al., 2014)
following surgery. One study found a decrease in depression from
32.7% at baseline, to 16.5% at 6–12 months, and 14.3% at 2–3 years
following surgery (de Zwaan et al., 2011). However, other studies
suggest that improvements following surgery may not be maintained
after the ﬁrst post-operative year (Mitchell et al., 2014) and depressive
symptoms may deteriorate in some patients (Ivezaj and Grilo, 2014).
Previous reports have often drawn on data from hospital-based series
that did not include control groups, often with short durations of
follow-up. The present study aimed to evaluate whether bariatric
surgery is associated with a reduction in clinical depression up to a
maximum of seven years following the procedure. A population-based
cohort provided the data source for an interrupted time-series design
with matched controls, facilitating a pragmatic evaluation of the
impact of BS on clinical depression recorded in primary care electronic
health records.
2. Methods
2.1. Study design and participants
A controlled interrupted time-series study was conducted, draw-
ing on data for obese participants who received bariatric surgery and
matched obese control participants who did not receive surgery, by
evaluating multiple time points both before and after the bariatric
surgical procedure. Electronic health records from primary care were
evaluated for clinical diagnoses of depression and prescription of
anti-depressant drugs in the three years before-, and seven years
after-, bariatric surgery.
Participants were selected from the UK Clinical Practice Research
Datalink (CPRD). The CPRD is a prospectively collected database of
research-quality primary care electronic health records including
demographic, clinical, diagnostic and prescribing information for appr-
oximately 6% of the UK population (Herrett et al., 2010, Williams et al.,
2012). Ethical approval for the study was given by the CPRD Inde-
pendent Scientiﬁc Advisory Committee (ISAC 13_089).
All participants with a record of bariatric surgery from 1st January
2000 to the 30th April 2012 were sampled, including laparoscopic
adjustable gastric banding (LAGB), gastric bypass and sleeve gas-
trectomy. The ﬁrst date on which surgery was recorded was taken as
the index date. The earliest index event was in 2002. Participants
aged less than 20 years or without a BMI record indicating obesity
(BMIZ30 kg/m2) prior to surgery were excluded. Participants with
BS recorded less than 12 months after the start of their record were
also excluded, because these records might have referred to BS pro-
cedures performed before the participant joined the general practice.
BS participants were individually matched with a cohort of con-
trol participants, matched for gender, age, BMI and index year. The
index date for control participants was the date on which they ﬁrst
entered their highest BMI category. All controls had a minimum of 12
months record before the index date. Nearest neighbour matching
was used to select the control cohort.
2.2. Outcomes and covariates
Clinical depression was identiﬁed through medical diagnoses for
depression recorded in clinical or referral records as well as through
prescriptions for anti-depressant drugs. Participant records were
divided into person-years before- and after-surgery. Individuals were
classiﬁed as having clinical depression in a given person-year if they
had a medical diagnosis of depression recorded in that year, or if they
were prescribed antidepressant drugs in the year and were ever
diagnosed with depression (Bhattarai et al., 2013). BMI was cate-
gorised using the World Health Organisation (WHO) criteria using
the most recent record prior to the index date. Co-morbidities were
evaluated including stroke, coronary heart disease (CHD) and
type 2 diabetes. Records for hypertension (blood pressure Z140/
90 mmHg), high cholesterol (total cholesterolZ5 mmol/L) and cur-
rent smoking status were evaluated. Participants were also classiﬁed
according to whether they were treated with anti-hypertensive or
lipid-lowering medications.
2.3. Analysis
Baseline characteristics in the surgery and control groups were
compared. Participant records were divided into one year periods
from up to three years before, to a maximum of seven years after,
the index date. The presence or absence of clinical depression was
evaluated for each one year period. A multiple logistic regression
analysis was conducted using person years as observations and the
presence or absence of clinical depression in each year as the
outcome. A model was ﬁtted to evaluate the effect of group (BS or
control); study year from three years before to seven years after
surgery; and time after surgery, included, for improved goodness-
of-ﬁt, as indicator variables for each post-operative year (Penfold
and Zhang, 2013). The reference category was all person-time
without surgery from the control group and the bariatric surgery
group before operation. The model was adjusted for gender, age,
baseline BMI, index year, type of BS procedure, prevalent diabetes
mellitus, coronary heart disease and stroke, smoking status, high
blood pressure and cholesterol, and treatment with anti-
hypertensive or lipid-lowering drugs. Robust variance estimates
were employed to adjust standard errors for clustering of person
years by participant.
3. Results
There were 4793 participants with bariatric surgery recorded;
1324 participants with bariatric surgery ﬁrst recorded less than one
year after the start of the patient record were excluded, as were 14
participants aged less than 20 years at the index date, and 401
participants with either no BMI record before surgery or BMI values
less than 30 kg/m2 prior to surgery. Nine participants with a record of
gastric band removal before the index date were also excluded. There
were then 3045 participants identiﬁed as having bariatric surgery for
obesity and 3045 matched controls. BS procedures included laparo-
scopic gastric banding (LAGB) in 1297 (43%), gastric bypass in 1265
(42%), sleeve gastrectomy in 477 (16%) and six undeﬁned type.
Utilisation of BS increased over the period and LAGB accounted for
97% of 104 procedures before 2006, but only 20% of 924 procedures
from 2012 onwards, with increasing use of gastric bypass and sleeve
gastrectomy. The median year of procedure was 2010, consequently
only a minority of participants contributed more than three years of
follow-up data.
Characteristics of the surgery and control participants at the index
date are presented in Table 1. The majority of surgical procedures
were conducted in women (79%) and in participants with morbid
obesity (65%). The mean age at surgery was 45.9 years. Participants
undergoing bariatric surgery more frequently had type 2 diabetes
(29% vs. 14%, Po0.001), hypercholesterolaemia (35% vs. 25%,
P¼0.022) and were more likely to be prescribed anti-hypertensive
drugs and statins than controls.
Table 2 shows the number of participants analysed by year
before and after surgery. There were 63% contributing to follow-up
after the end of two years and 31% in the ﬁfth year of follow-up. In
the year prior to surgery, 36% of surgery participants met the
criteria for prevalent clinical depression in comparison to 21% of
control participants (Fig. 1 and Table 2). In the two years following
surgery, this reduced to 32% in the participants who underwent
surgery before rising to pre-surgery levels (37%) in the seventh year
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of follow-up. Rates of depression in control participants remained
stable. In the surgery group, 41% of participants were prescribed
anti-depressants in the year leading up to surgery, falling to 36% in
the subsequent year. The proportion of participants prescribed anti-
depressants began to rise again after the ﬁrst year and surpassed
pre-surgery levels in the ﬁfth year following bariatric surgery.
Table 3 presents the results of the multiple logistic regression
model for the outcomes of clinical depression and antidepressant
prescribing. Compared with control participants, the between-group
effect shows that BS participants were more likely to be diagnosed
with clinical depression (odds ratio 2.02, 95% conﬁdence interval
1.75–2.33, Po0.001) or to be prescribed antidepressant drugs (1.97,
1.72–2.25, Po0.001). There was evidence of increasing trends in
diagnosis of depression and prescription of antidepressant drugs
over the study period. Estimation of the effect of time since surgery,
in comparison to all person-time without surgery from both groups,
revealed a reduction in clinical depression and antidepressant
prescribing in the ﬁrst three years following the procedure. The
adjusted relative odds of clinical depression were 0.82 (0.78–0.87,
Po0.001) and 0.83 (0.76–0.90, Po0.001) in the ﬁrst two years
following the procedure. Similar changes were observed for the
related outcome of antidepressant prescribing. However, from the
fourth post-operative year onwards there was no longer any
evidence for a reduction in clinical depression or antidepressant
prescribing.
There was no evidence that the effect of bariatric surgery varied by
type of procedure (test for interaction, P¼0.2885). Table 4 presents the
prevalence of depression for each of the three procedures included in
the study, after omitting six with undeﬁned procedure type. There
were more participants with LAGB at long durations of follow-up
while fewer than 25% of participants receiving sleeve gastrectomy, and
35% receiving gastric bypass, contributed data after the end of three
years follow-up because these procedures were utilised more recently.
The effect in each sub-group was generally similar to the one observed
overall, and in the absence of an interaction effect, possible subgroup
differences were not explored further.
Table 5 shows the results divided by depression status in the
pre-operative year. Among participants who were not depressed in
the pre-operative year, the prevalence of depression increased to
18% in the 6th post-operative year, while up to 9% were depressed
two years before the procedure. Among participants who were
depressed in the pre-operative year, the prevalence of depression
was generally close to 75% post-operatively. However, in the second
pre-operative year, 77% were depressed. These results are consistent
with depression being episodic and frequent in this population.
4. Discussion
4.1. Main ﬁndings
Patients undergoing bariatric surgery have higher levels of dep-
ression compared with other obese patients with similar body mass
index and of the same age and sex. Frequent comorbidities, including
diabetes mellitus, might be associated with this increased frequency
of depression. The results of the present study indicate that bariatric
surgery in obese patients may be associated with a modest reduction
in the prevalence of depression, and the use of anti-depressant
medications in primary care, but these effects do not appear to
persist more than three years following the procedure. The reasons
why patients with depressive illness are disproportionately repre-
sented among patients undergoing bariatric surgery in this popula-
tion are unclear. In the UK, only a very small minority of patients
with severe obesity undergo bariatric surgery and it is possible that
psychological symptoms may be one of the considerations that
inﬂuence whether an obese patient receives surgery. Obese patients
seeking treatment may generally have higher levels of psychological
distress. In a study in Germany, Herpertz et al. (2006) found that
patients undergoing bariatric surgery had similar levels of depression
to those receiving non-surgical weight-loss therapy, with both being
higher than obese controls. Comparison of patients who were either
depressed, or not depressed, in the pre-operative year showed a
Table 1
Comparison of baseline characteristics of BS participants and controls. Figures are frequencies (column per cent) except where indicated.
BS cases Controls
Frequency 3045 3045
Female (%) 2406 (79) 2521 (83) Matched
Age (years, mean, SD) 45.9 (10.2) 44.3 (14.8) Matched
BMI (kg/m2, mean, SD) 44.0 (8.3) 43.5 (7.6) Matched
BMI category (kg/m2) 30.0 to 34.9 394 (13) 351 (12) Matched
35.0 to 39.9 677 (22) 681 (22)
Z40.0 1974 (65) 2013 (66)
Comorbidity Diabetes 878 (29) 424 (14) o0.001
Coronary heart disease 134 (4) 102 (3) 0.034
Stroke 36 (1) 38 (1) 0.815
Current smoking 502 (16) 675 (22) o0.001
Blood pressure Z140/90 mm Hg 834 (27) 900 (30) 0.001
Cholesterol Z5 mmol/L 1080 (35) 760 (25) 0.022
Anti-hypertensive drugs prescribed 1561 (51) 1074 (35) o0.001
Statins prescribed 864 (28) 486 (16) o0.001
Index year (median IQR) 2010 (2009–2012) 2010 (2009–2012) Matched
Table 2
Changes before and after surgery in diagnosis and treatment of depression. Figures
are frequencies for person years and row per cent for depression and antidepres-
sant prescribing.
Year Participants
contributing
person time
in year
Antidepressants
prescribed in
year (row %)
Depression
recorded in
year (row %)
Meeting
criteria of
clinical
depression in
year (row %)
BS
cases
Controls BS
cases
Controls BS
cases
Controls BS
cases
Controls
3 to 2 2856 2560 38 19 12 6 34 16
2 to 1 3045 3045 40 22 12 7 34 19
1 to 0 3045 3045 41 25 9 7 36 21
0–1 3045 3045 36 25 6 6 32 21
1–2 2488 2786 37 24 7 4 32 20
2–3 1916 2014 38 24 7 5 33 20
3–4 1392 1369 40 23 6 4 34 19
4–5 935 914 43 23 6 4 34 18
5–6 574 570 44 24 7 4 37 19
6–7 335 369 43 26 6 2 37 20
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Fig. 1. Prevalence of clinical depression for bariatric surgery cases (black) and controls (grey) for three years before and seven years after index date.
Table 3
Logistic regression analysis of the association of bariatric surgery with clinical depression and antidepressant prescribing.
Clinical depression P value Antidepressant prescribing P value
Odds ratio
(95% conﬁdence interval)
Odds ratio
(95% conﬁdence interval)
Effect of groupa Control group Ref. Ref.
Bariatric surgery group 2.02 (1.75–2.33) o0.001 1.97 (1.72–2.25) o0.001
Effect of study yearb Year 1.02 (1.01–1.04) 0.007 1.04 (1.03–1.06) o0.001
Effect of time since surgeryc Time without surgery Ref. Ref.
First post-operative year 0.82 (0.78–0.87) o0.001 0.79 (0.74–0.84) o0.001
Second post-operative year 0.83 (0.76–0.90) o0.001 0.79 (0.72–0.86) o0.001
Third post-operative year 0.87 (0.78–0.97) 0.014 0.82 (0.73–0.91) o0.001
Fourth post-operative year 0.89 (0.78–1.02) 0.100 0.87 (0.76–0.99) 0.039
Fifth post-operative year 0.87 (0.74–1.04) 0.123 0.87 (0.74–1.03) 0.107
Sixth post-operative year 1.01 (0.82–1.25) 0.910 0.99 (0.80–1.22) 0.912
Seventh post-operative year 0.99 (0.76–1.29) 0.959 1.04 (0.81–1.35) 0.747
Odds ratios were adjusted for each of the variables shown as well as age, sex, index year, type of procedure, prevalent diabetes, stroke and coronary heart disease, high blood
pressure, high cholesterol, smoking, prescription of antihypertensive drugs and statins.
a effect of group across all years, adjusted for study year and time since surgery.
b effect of study year adjusted for group and time since surgery.
c effect of time since surgery, using time before surgery for reference, adjusting for group and study year.
Table 4
Clinical depression following different bariatric surgical procedures. Figures are
number of participants at risk in year (N) and proportion (%) with depression.
Year LAGB Gastric bypass Sleeve gastrectomy
N Depression
(%)
N Depression
(%)
N Depression
(%)
3 to 2 1207 32 1195 36 448 34
2 to 1 1297 33 1265 35 477 35
1 to 0 1297 37 1265 36 477 33
0–1 1297 31 1265 33 477 31
1–2 1160 32 980 32 344 29
2–3 1003 35 682 33 227 30
3–4 826 34 444 36 119 27
4–5 645 35 229 32 59 27
5–6 478 38 65 37 30 27
6–7 300 37 18 33 17 29
There was no evidence that the effect of bariatric surgery on clinical depression
varied by type of procedure (test for interaction, P¼0.2885).
Table 5
Prevalence of depression by year following bariatric surgery divided by presence or
absence of depression in pre-operative year. Figures are number of participants at
risk in year (N) and proportion (%) with depression.
Year Depressed in pre-operative
year
Not depressed in pre-operative
year
N Depression (%) N Depression (%)
3 to 2 1036 77 1820 9
2 to 1 1097 84 1948 6
1 to 0 1097 100 1948 0
0–1 1097 79 1948 5
1–2 889 74 1599 8
2–3 664 74 1252 12
3–4 479 75 913 13
4–5 320 73 615 14
5–6 203 73 371 18
6–7 113 77 222 16
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decline in depression in the former and an increase in the latter after
surgery. This is compatible with regression to the mean and is
consistent with the episodic nature of depression symptoms. Our
results do not provide strong evidence that patients should be
prioritised in the hope that bariatric surgery will provide long-term
relief of clinical features of depression, even though short term
effects might be judged clinically relevant.
4.2. Comparison with previous studies
Previous studies have generally shown larger effects than the
present study but these generally used samples drawn from specia-
list centres that might be susceptible to bias. One of the largest
studies was conducted by the Longitudinal Assessment of Bariatric
Surgery-2 (LABS-2) group. The included 2148 participants from 10 US
hospitals with Beck Depression Inventory recorded at baseline and at
least one follow-up within three years of the procedure. There were
40% who reported treatment for depression before surgery, while
28% had mild depressive symptoms and 5% moderate or severe
depressive symptoms. The proportionwith any depressive symptoms
was less than 10% in the ﬁrst year after surgery but increased to 16%
at three years. A similar pattern of change in depressive symptoms
over time was reported by Burgmer et al. (2014), in a four year study
of 148 participants. However, changes in use of antidepressant
medication in the LABS-2 study were modest with 35% using anti-
depressant medication before operation and 28% in the second and
third years following the procedure. These results emphasise the
importance of long follow-up in future studies as well as the
evaluation of different measures of depression. In the Swedish Obese
Subjects (SOS) study, a battery of health-related quality of life
measures, including the Hospital Anxiety and Depression Scale, sho-
wed improvement followed by deterioration (Karlsson et al., 2007).
An initial improvement is associated with the period of greatest
weight loss in the ﬁrst two years following surgery, sometimes
viewed as a ‘honeymoon period’ (Andersen, 2014), followed by a
subsequent deterioration associated with weight regain (Karlsson et
al., 2007). However, in the SOS study there was evidence of some
improvement in depression symptoms up to 10 years of follow-up.
Premorbid depression was less frequent in the SOS study than in the
present sample.
4.3. Strengths and limitations
This study had the strengths of a large, population-based sample of
patients undergoing bariatric surgery with prospectively recorded data
for depression diagnoses and antidepressant prescribing. The inter-
rupted time series design is generally considered to be more resistant
to bias than other non-randomised designs (Ramsay et al., 2003).
However, there were clear differences between the intervention and
matched comparison group with respect to the outcome of interest,
indicating that individuals undergoing surgery represent a highly
selected group that is not typical of all patients with the same body
mass index, age and sex. Patients undergoing surgery may receive a
package of supportive care and improved clinical management to
prepare them for surgery, which may confound the effect of the
surgical procedure. Patients in the control group received the usual
care offered at their general practice, which was unlikely to include
standardised management of obesity or depression. The types of
surgical procedure and patient case-mix changed over time and, tho-
ugh access remained restricted, the numbers of procedures increased.
There were small numbers of patients with long follow-up with
reduced statistical power for evaluation of later time points. Further-
more, there is a risk of bias because patients operated on longer ago
may have different characteristics from those operated on more
recently, with shorter periods of follow-up. Use of clinical data may
also introduce bias because patients must consult with their physician,
and have their symptoms recognised, before a depression diagnosis
may be recorded. An important limitation is that there was very
limited recording of body weight during the period of follow-up and
we cannot determine whether changes in depression were associated
with weight-loss or regain. Our assessment of depression was based
on clinical diagnoses and antidepressant prescribing; the limited
changes observed over time might result from difﬁculty in stopping
antidepressant therapy once initiated. A previous CPRD study found
that depression is often treated with short-term courses of anti-dep-
ressant medications, with only a small proportion of patients being
prescribed drugs over a long period for chronic depression (Moore
et al., 2009). The high rates of anti-depressant use observed in this
study may represent met need and not merely the result of repeat
prescribing to patients who might no longer require clinical treatment
for depression. Several previous studies used self-report measures to
evaluate depressive symptoms and these measures might be asso-
ciated with greater sensitivity for depression and responsiveness to
change (Bjelland et al., 2002; Beck et al., 1988). For all of the reasons, it
would be desirable to test hypotheses using well-designed rando-
mised trials with prospective documentation of depression.
4.4. Conclusion
The results of this large population-based study suggest that
bariatric surgery may have only a limited and short-lived effect on
clinical depression. However, we caution that patients are pre-
sently highly-selected for bariatric surgery. If bariatric surgery
were to be more widely accessible, it is possible that different
effects might be observed. Randomised studies of the effect of
bariatric surgery on depression are required.
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